Cargando…
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
OBJECTIVE—Fibroblast growth factor 21 (FGF21) has emerged as an important metabolic regulator of glucose and lipid metabolism. The aims of the current study are to evaluate the role of FGF21 in energy metabolism and to provide mechanistic insights into its glucose and lipid-lowering effects in a hig...
Autores principales: | Xu, Jing, Lloyd, David J., Hale, Clarence, Stanislaus, Shanaka, Chen, Michelle, Sivits, Glenn, Vonderfecht, Steven, Hecht, Randy, Li, Yue-Sheng, Lindberg, Richard A., Chen, Jin-Long, Jung, Dae Young, Zhang, Zhiyou, Ko, Hwi Jin, Kim, Jason K., Véniant, Murielle M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606881/ https://www.ncbi.nlm.nih.gov/pubmed/18840786 http://dx.doi.org/10.2337/db08-0392 |
Ejemplares similares
-
FGF21 Promotes Metabolic Homeostasis via White Adipose and Leptin in Mice
por: Véniant, Murielle M., et al.
Publicado: (2012) -
Growth differentiation factor 15 as a potential therapeutic for treating obesity
por: Hale, Clarence, et al.
Publicado: (2020) -
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
por: Sarruf, David A., et al.
Publicado: (2010) -
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
por: Lu, Shu-Chen, et al.
Publicado: (2021) -
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Killion, Elizabeth A., et al.
Publicado: (2020)